Prothena Corp PLC (NAS:PRTA)
$ 20.81 0.6 (2.97%) Market Cap: 1.12 Bil Enterprise Value: 584.98 Mil PE Ratio: 0 PB Ratio: 2.23 GF Score: 68/100

Prothena Corporation PLC at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:00PM GMT
Release Date Price: $69.95 (-3.24%)
Mike Yee
Jefferies - Analyst

All right. Thank you for joining us on the next session here at the Jefferies Healthcare Conference. I'm Mike Yee, Managing Director and senior biotechnology analyst. And I have the pleasure of having the President and CEO of Prothena up here with us, Gene Kinney. Thanks for joining us, Gene.

Gene Kinney
Prothena Corporation plc - President, CEO & Director

Thanks for having us, Mike.

Mike Yee
Jefferies - Analyst

Absolutely. You have done a fantastic job building out a whole portfolio of products, specifically a pipeline of products, particularly around neurodegenerative diseases, protein misfolding, and we'll get to even vaccination as well for neurodegeneration.

Gene Kinney
Prothena Corporation plc - President, CEO & Director

Yup.

Questions & Answers

Mike Yee
Jefferies - Analyst

And so there's a lot to talk about. I would love to just start off first by asking about your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot